Catalyst Wire Dossier Catalyst Wire Dossier

Lexeo PKP2 gene therapy

· Lexeo Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lexeo PKP2 gene therapy, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for ACM Due to a PKP2 Pathogenic Variant [Phase 1, Phase 2]

See pricing